Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"
Launched by CENTRE LEON BERARD · Oct 24, 2023
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is called "Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After 'Magic Massages.'" It aims to understand how a special massage training for parents can improve their child's emotional well-being during treatment for acute lymphoblastic leukemia, a type of blood cancer common in children. The study will involve parents of children aged 2 to 12 who are currently receiving treatment. Parents will need to agree to learn the "Magic Massage" technique, which is intended to help improve their child's quality of life by reducing feelings of anxiety and depression.
Eligible parents must be the primary caregiver of a child diagnosed with leukemia and should be able to understand French. Throughout the study, parents will complete surveys about their child's emotional health and the relationship they have with their child. They will provide feedback before the training, and again three and six weeks later. The researchers hope that this training will not only help the children feel better emotionally but also strengthen the bonds between parents and their children. Overall, this study could lead to broader use of these massage techniques in pediatric care for other conditions in the future.
Gender
ALL
Eligibility criteria
- Criteria for including parents :
- • Be the parent of a patient with acute lymphoblastic leukaemia (ALL) in the induction phase of treatment (at least one-month post-diagnosis and up to 50 days post-diagnosis, according to the ALL Together 2023 treatment protocol), aged between 2 and 12 years at diagnosis and under the care of a study investigating center.
- • Have agreed to undergo training in the Magic Massage technique at the time of the study and at one of the study's investigating centers
- • Be able to understand, speak, read and write French
- • Have been informed of the study and not to have objected
- Criteria for not including parents:
- • Have refused to take part in the "Magic Massages" training during the study or have already done so prior to inclusion.
- • Have refused or to be incapable of making an informed objection
- • Be the 2nd parent of a patient with ALL for whom a 1er parent is already included in the study.
- • Be deprived of liberty by a court or administrative order
- • Inclusion criteria for children
- • Have ALL and be in the induction phase of treatment (at least one-month post-diagnosis and up to 50 days post-diagnosis, according to the ALL Together 2023 treatment protocol).
- • Be 2 to 12 years of age at diagnosis
- • Be under the care of one of the study's investigating centers
- • Have been informed of the study in a manner appropriate to their abilities and not to have opposed it
- Criteria for non-inclusion of children:
- • Not be followed for the duration of the study
- • Have refused to take part in the study
- • Be deprived of liberty by a court or administrative order
About Centre Leon Berard
Centre Léon Bérard is a leading cancer research and treatment center located in Lyon, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. As a prominent institution in the field of cancer management, it integrates cutting-edge research, multidisciplinary expertise, and state-of-the-art facilities to enhance therapeutic outcomes and improve the quality of life for patients. The center is committed to fostering collaboration among researchers, healthcare professionals, and industry partners to drive the development of novel treatments and to contribute significantly to the global understanding of cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Véronique CHRISTOPHE, PR
Study Director
Centre Leon Berard
Amélie ANOTA, PHD
Study Director
Centre Leon Berard
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported